↓ Skip to main content

Cochrane Database of Systematic Reviews

Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

Overview of attention for article published in Cochrane database of systematic reviews, March 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter
8 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley
Title
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
Published in
Cochrane database of systematic reviews, March 2021
DOI 10.1002/14651858.cd013316.pub2
Pubmed ID
Authors

Alexandra McAleenan, Claire Kelly, Francesca Spiga, Ashleigh Kernohan, Hung-Yuan Cheng, Sarah Dawson, Lena Schmidt, Tomos Robinson, Sebastian Brandner, Claire L Faulkner, Christopher Wragg, Sarah Jefferies, Amy Howell, Luke Vale, Julian P T Higgins, Kathreena M Kurian

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 17%
Student > Postgraduate 5 10%
Student > Doctoral Student 3 6%
Student > Ph. D. Student 3 6%
Researcher 3 6%
Other 7 15%
Unknown 19 40%
Readers by discipline Count As %
Medicine and Dentistry 14 29%
Biochemistry, Genetics and Molecular Biology 4 8%
Unspecified 2 4%
Nursing and Health Professions 2 4%
Psychology 2 4%
Other 4 8%
Unknown 20 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2022.
All research outputs
#5,630,610
of 21,257,749 outputs
Outputs from Cochrane database of systematic reviews
#7,646
of 12,104 outputs
Outputs of similar age
#110,134
of 326,490 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 44 outputs
Altmetric has tracked 21,257,749 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 12,104 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.8. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,490 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.